Jul 18, 2023
327:298
For every 298 shares held, investors received 327. The price per share adjusted from $6640.00 to $6051.13.
The split itself did not change the total investment value.
Cellid Co., Ltd. (KRX:299660) operates in the Pharmaceuticals: major industry.
Cellid Co., Ltd. company overviewCellid Co., Ltd.'s most recent stock split was on July 18, 2023. It was a 327-for-298 forward split, so shareholders received 327 shares for every 298 they held.
Cellid Co., Ltd. has split its stock once. This history records one forward split, on July 18, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Cellid Co., Ltd.'s 327-for-298 split on July 18, 2023, every 298 shares became 327 shares.
Cellid Co., Ltd. has not announced a new split in our records. Its most recent split was on July 18, 2023, 3 years ago. Companies announce splits in advance, and any new KRX:299660 split will appear on this page.
Already premium?